Biopharmaceutical Products Case Study

2744 Words6 Pages

Introduction
In modern medicine industry, biological techniques are widely used in the production of pharmaceuticals. Pharmaceutical biotechnology products are the medical products extracted from native biological sources and used for therapeutic or in vivo diagnostic purposes. Normally, these biological products include proteins, such as antibodies, and nucleic acids, such as DNA and RNA. However, as the high sensitivity to external environment, the stability of biopharmaceutical products are easily affected by some physicochemical factors, biological factors, etc. As a result, during the process of manufacturing, packaging and storage, biopharmaceutical products have a high risk of degradation which could lead to significantly negative influences …show more content…

Stability of pharmaceutical biotechnology products emphasizes that, during the period of storage and use, the properties and characteristics of biopharmaceutical products need be as same as those at the time of production, and a product could be defined as failure to meet its specification when it generates “significant change”. For pharmaceutical biotechnology products, the molecular conformation and biological activity of components both depend on covalent and non-covalent forces, so strict and comprehensive stability studies should be performed for these biopharmaceutical products. Normally, the active components of biopharmaceutical products include proteins, plasmids or polypeptides, which are extracted from cell culture, tissues or through the use of recombinant DNA technologies. As these products are extremely sensitive to the external environmental factors, such as temperature, hydrolysis, radiation, oxidation and so forth, these products must be able to maintain their quality in the whole intended storage period. As a result, to ensure the activity and to avoid degradation, before the new biopharmaceutical products have access to the market, manufacturers need to perform comprehensive stability studies, including physical testing, chemical testing, biological testing etc., to evaluate these products under different environmental situations …show more content…

- Light: Consult corresponding regulatory agencies to determine the guidelines for testing.
- Container: Manufacturers need submit the stability data about all the containers which will enter the market. The interaction between biological products and containers may lead to the change of product quality. As a result, stability studies should contain samples in the inverted, horizontal or upright position so as to analyse the influence of containers on products.
- Stability after reconstitution of freeze-dried product: For freeze-dried biopharmaceutics, maximum storage period should be demonstrated by stability testing, and some labelling should meet relevant regional requirements.

More about Biopharmaceutical Products Case Study

Open Document